Guizhou Xinbang Pharmaceutical Co.,Ltd.’s Net Profit Rose 1.9% in First Quarter of 2022

Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 79.5 million yuan in the first quarter of 2022, up 1.9% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 8.1% year-on-year.

At the end of the reporting period, it had 9.5 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 27.6%.